Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Chia Tai Shahe Pharmaceutical is a specialized pharmaceutical manufacturer based in Quzhou, China, and operates as a subsidiary of Sino Biopharmaceutical Limited. The company is primarily engaged in the production of chemical drugs across various therapeutic categories, including cardiovascular, gastrointestinal, and anti-infective treatments. Its facilities are GMP-certified, supporting the large-scale production of oral solid dosage forms such as tablets and capsules. Chia Tai Shahe plays a key role in the parent group's supply chain, focusing on high-quality generic medications for the Chinese healthcare market. The company integrates research and development with manufacturing to maintain a competitive portfolio of essential medicines. As part of the broader CP Pharmaceutical Group, it benefits from extensive distribution networks and centralized R&D resources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Chiatai Shahe Pharmaceutical.